Clinical Breakthrough Propels Compass Therapeutics (CMPX) Stock Higher
Fahim Awan
April 1, 2025
Following the release of encouraging clinical study findings, Compass Therapeutics, Inc. (NASDAQ: CMPX) stock is seeing a significant increase in value. CMPX shares were up